Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month.
Magalini A, Puoti M, Putzolu V, Quiros-Roldan E, Forleo MA, Rossi S, Zaltron S, Spinetti A, Zanini B, Zonaro A, Solfrini R, Carosi G. Magalini A, et al. Among authors: zaltron s. J Clin Lab Anal. 2000;14(3):120-4. doi: 10.1002/(sici)1098-2825(2000)14:3<120::aid-jcla6>3.0.co;2-#. J Clin Lab Anal. 2000. PMID: 10797610 Free PMC article. Clinical Trial.
Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone.
Puoti M, Cadeo GP, Putzolu V, Forleo MA, Barni MC, Cristini G, Rossi S, Spinetti A, Zaltron S, Zanini B, Quiros-Roldan E, Paraninfo G, Gargiulo F, Carosi G. Puoti M, et al. Among authors: zaltron s. Dig Liver Dis. 2001 Mar;33(2):163-72. doi: 10.1016/s1590-8658(01)80073-6. Dig Liver Dis. 2001. PMID: 11346146 Clinical Trial.
Mortality for liver disease in patients with HIV infection: a cohort study.
Puoti M, Spinetti A, Ghezzi A, Donato F, Zaltron S, Putzolu V, Quiros-Roldan E, Zanini B, Casari S, Carosi G. Puoti M, et al. Among authors: zaltron s. J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):211-7. doi: 10.1097/00126334-200007010-00003. J Acquir Immune Defic Syndr. 2000. PMID: 10969344
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting.
Fabbiani M, Lombardi A, Colaneri M, Del Poggio P, Perini P, D'Ambrosio R, Degasperi E, Dibenedetto C, Giorgini A, Pasulo L, Maggiolo F, Castelli F, Brambilla P, Spinelli O, Re T, Lleo A, Rumi M, Uberti-Foppa C, Soria A, Aghemo A, Lampertico P, Baiguera C, Schiavini M, Fagiuoli S, Bruno R; NAVIGATORE-Lombardia Study Group. Fabbiani M, et al. J Viral Hepat. 2021 Mar;28(3):558-568. doi: 10.1111/jvh.13454. Epub 2021 Jan 2. J Viral Hepat. 2021. PMID: 33306247
Chronic HCV infection: epidemiological and clinical relevance.
Zaltron S, Spinetti A, Biasi L, Baiguera C, Castelli F. Zaltron S, et al. BMC Infect Dis. 2012;12 Suppl 2(Suppl 2):S2. doi: 10.1186/1471-2334-12-S2-S2. Epub 2012 Nov 12. BMC Infect Dis. 2012. PMID: 23173556 Free PMC article. Review.
33 results